SinoMab BioScience grants 18,026,040 share options at HK$ 1.2 each

• SinoMab BioScience granted 18,026,040 share options to two eligible persons on July 24, 2026 under its 2022 Share Option Scheme.
• Executive Director and COO Fang Liang received 11,093,040 options; one other employee received 6,933,000 options.
• Exercise price set at HK$ 1.2 per share; options run from the vesting start date to July 23, 2036.
• Vesting starts no earlier than July 24, 2027; vesting tied to annual performance evaluation, with part of the employee grant linked to business milestones.
• 34,019,409 shares remain available for future grants under the scheme mandate; no clawback mechanism specified for this grant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260724-12256156), on July 24, 2026, and is solely responsible for the information contained therein.